Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $175.00 price target on Aligos Therapeutics Inc. (NASDAQ: ALGS).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE